Установить Steam
войти
|
язык
简体中文 (упрощенный китайский)
繁體中文 (традиционный китайский)
日本語 (японский)
한국어 (корейский)
ไทย (тайский)
Български (болгарский)
Čeština (чешский)
Dansk (датский)
Deutsch (немецкий)
English (английский)
Español - España (испанский)
Español - Latinoamérica (латиноам. испанский)
Ελληνικά (греческий)
Français (французский)
Italiano (итальянский)
Bahasa Indonesia (индонезийский)
Magyar (венгерский)
Nederlands (нидерландский)
Norsk (норвежский)
Polski (польский)
Português (португальский)
Português-Brasil (бразильский португальский)
Română (румынский)
Suomi (финский)
Svenska (шведский)
Türkçe (турецкий)
Tiếng Việt (вьетнамский)
Українська (украинский)
Сообщить о проблеме с переводом
The impetus for this decision was reports from Scandinavia of 30 serious blood clot events following the administering of five million doses of the vaccine in question which is manufactured by AstraZeneca, the British-Swedish multinational pharmaceutical company.
So is the vaccine safe? To answer that, we can look at the data from trials conducted on the vaccine before it was approved by the European Medicines Agency and other regulators. They showed an excellent safety profile and no evidence of induced blood clotting. And despite the current concerns, emerging data does not conclusively suggest any increase in clotting risk either.
-"Studley Mancannon" c.2021 17/03